KGOF

Late Stage · Growth

Kurma Growth Opportunities

An investment fund dedicated to Growth Capital investments for both therapeutic and non-therapeutic solutions in high unmet need diseases.

167M€
Fund size
2024
1st closing
8
Portfolio companies
3
Team members

An investment fund dedicated to Growth Capital investments for both therapeutic and non-therapeutic solutions in high unmet need diseases.

KGOF aims to invest into SMEs raising growth capital through late-stage, crossover and/or public rounds of finance in the field of therapeutics, diagnostics and HealthTech as well as opportunistically in medical devices (MedTech). Majority focus in EU countries and also into existing portfolio companies of Kurma Biofund / Diagnostic Funds.

Size167 million euros
Closing2024
InterventionLate-stage Growth and Cross-over
SectorBiotechnology, therapeutic and Diagnostics, HealthTech, MedTech Life, Science Tools
GeographyEurope and outside of Europe
SFDRArticle 8

Investment Team

The Growth team

Portfolio

Our companies

Latest News

Stay informed

Our Strategies

Explore our other strategies